Dermatomyositis

Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1γ can result in experimental myositis
Naoko Okiyama, Yuki Ichimura, Miwako Shobo, Ryota Tanaka, Noriko Kubota, Akimasa Saito, Yosuke Ishitsuka, Rei Watanabe, Yasuhiro Fujisawa, Yoshiyuki Nakamura, Akihiro Murakami, Hisako Kayama, Kiyoshi Takeda, Manabu Fujimoto

Annals of the Rheumatic Diseases Apr 2021, annrheumdis-2020-218661; DOI: 10.1136/annrheumdis-2020-218661
Response to: ‘Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort’ by Costa et al
Latika Gupta, Durga Prasanna Misra, Vishwesh Agarwal, Suma Balan, Vikas Agarwal

Annals of the Rheumatic Diseases Apr 2021, 80 (4) e47; DOI: 10.1136/annrheumdis-2020-217953
Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis
Yuchuan Ding, Baozhen Huang, Yuan Wang, Jun Hou, Ying Chi, Zhixuan Zhou, Jianguo Li

Annals of the Rheumatic Diseases Apr 2021, 80 (4) 543-545; DOI: 10.1136/annrheumdis-2020-218582
Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis
Hanna Kim, Samantha Dill, Michelle O'Brien, Laura Vian, Xiaobai Li, Manuk Manukyan, Minal Jain, Lilian W Adeojo, Jomy George, Maria Perez, Alexei A Grom, Michelle Sutter, Brian M Feldman, Lawrence Yao, Michelle Millwood, April Brundidge, Dominique C Pichard, Edward W Cowen, Yinghui Shi, Shajia Lu, Wanxia Li Tsai, Massimo Gadina, Lisa G Rider, Robert A Colbert

Annals of the Rheumatic Diseases Mar 2021, 80 (3) 406-408; DOI: 10.1136/annrheumdis-2020-218690
Correspondence on ‘EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups’
Irfan Mohammad, Phani Kumar Devarasetti, Liza Rajasekhar

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219426; DOI: 10.1136/annrheumdis-2020-219426
Response to: ‘Correspondence on ‘Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis’’ by Takanashi et al
Iago Pinal-Fernandez, Maria Casal-Dominguez, Jose Cesar Milisenda, Andrew Lee Mammen

Annals of the Rheumatic Diseases Jan 2021, annrheumdis-2020-219767; DOI: 10.1136/annrheumdis-2020-219767
Correspondence on ‘Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis’
Satoshi Takanashi

Annals of the Rheumatic Diseases Dec 2020, annrheumdis-2020-219677; DOI: 10.1136/annrheumdis-2020-219677
On using machine learning algorithms to define clinically meaningful patient subgroups
Rachel Knevel, Tom WJ Huizinga

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e154; DOI: 10.1136/annrheumdis-2019-215959
Augmented versus artificial intelligence for stratification of patients with myositis
Michael Mahler, Brenden Rossin, Olga Kubassova

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e162; DOI: 10.1136/annrheumdis-2019-216000
Response to ‘Augmented vs. artificial intelligence for stratification of patients with myositis’ by Mahler et al
Alain Meyer, Lionel Spielmann, François Séverac

Annals of the Rheumatic Diseases Dec 2020, 79 (12) e163; DOI: 10.1136/annrheumdis-2019-216014

Main menu

Dermatomyositis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Dermatomyositis

Pages